Tag: Pharma

Cipla Limited has announced that it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza.................

Takeda Pharma has introduced innovative Gastrointestinal portfolio for patients with Inflammatory Bowel Diseases (IBD) and Ulcerative Colitis and Crohn's Disease. Kynteles is likely to benefit patients with a low risk of serious or opportunistic infections like Tuberculosis...................

Nearly 35% of the operations of the pharma companies need to be shifted digital, according to the survey of C Com Digital on COVID-19 impact. The study also saw that pharmaceutical companies are considering dedicating about 5% to 10% of their marketing budget towards creating webinars and online communications.....................

The contribution to the PM Cares Fund aims to support patients and the Government to contain the spread of the disease.................

The virtual event was attended by life sciences industry professionals aimed at transforming and digitalizing the life sciences industry in India. Speakers from Biocon, IPCA, Skanray, Sahajanand Medical Technologies, Lupin, Agappe Diagnostics, Stryker, Brainsight, COMOFI Medtech, HCL Technologies and Jamia Milia Islamia University shared their knowledge and know-how.............

Cipla signs a distribution agreement with Roche Products (India) Pvt. Ltd. to expand scope of the partnership to include, marketing and distribution of Roche’s trademark oncology drugs - Trastuzumab (Herclon), Bevacizumab (Avastin) and Rituximab (Ristova) in India.........................

Sun Pharma and Hikma have entered into an exclusive licensing agreement for ILUMYA for the Middle East and North Africa regions...................

The pharma industry received accolades from the Commerce Minister, Piyush Goyal for its extra-ordinary performance, in ensuring that the country did not face any type of shortage of medicines during this period....................

In a webinar, the top Indian officials presented the sectoral view and the investment opportunities in the pharmaceutical and medical device industry in India to Japanese industry representatives.......................

With recent advances in genome sequencing and data availability, it is high time that the Indian drug majors focus on tapping the vast potential of the innovative immune profiling field for the development of novel therapies.......................